Continuing America's leadership : realizing the promise of precision medicine for patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... May 5, 2015 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2017 |
Descrizione fisica | 1 online resource (iii, 41 pages) |
Collana | S. hrg. |
Soggetto topico |
Medical innovations - United States
Drug development - United States Medical technology - United States Pharmaceutical technology - United States Drug development Medical innovations Medical technology Pharmaceutical technology |
Soggetto genere / forma | Legislative hearings. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Continuing America's leadership |
Record Nr. | UNINA-9910705683403321 |
Washington : , : U.S. Government Publishing Office, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Continuing America's leadership : the future of medical innovation for patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... April 28, 2015 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2017 |
Descrizione fisica | 1 online resource (iii, 62 pages) |
Collana | S. hrg. |
Soggetto topico |
Medical innovations - United States
Drug development - Technological innovations - United States Medical instruments and apparatus - Technological innovations - United States Therapeutics - Technological innovations - United States Pharmaceutical technology - United States |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Continuing America's leadership |
Record Nr. | UNINA-9910705681903321 |
Washington : , : U.S. Government Publishing Office, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Gene jockeys : life science and the rise of biotech enterprise / / Nicolas Rasmussen |
Autore | Rasmussen Nicolas <1962-> |
Pubbl/distr/stampa | Baltimore, Maryland : , : Johns Hopkins University Press, , 2014 |
Descrizione fisica | 1 online resource (260 p.) |
Disciplina | 660.6 |
Soggetto topico |
Biotechnology - United States
Entrepreneurship - United States Pharmaceutical technology - United States |
Soggetto genere / forma | Electronic books. |
ISBN | 1-4214-1341-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Biology, industry, and the Cold War -- The insulin trophy -- Growing pains : commercial strains on a way of life -- The interferon derby : markets in credit, tournaments of value -- EPO : the making of the biotech blockbuster -- tPA the end of the beginning. |
Record Nr. | UNINA-9910465222003321 |
Rasmussen Nicolas <1962->
![]() |
||
Baltimore, Maryland : , : Johns Hopkins University Press, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Gene jockeys : life science and the rise of biotech enterprise / / Nicolas Rasmussen |
Autore | Rasmussen Nicolas <1962-> |
Pubbl/distr/stampa | Baltimore, Maryland : , : Johns Hopkins University Press, , 2014 |
Descrizione fisica | 1 online resource (260 p.) |
Disciplina | 660.6 |
Soggetto topico |
Biotechnology - United States
Entrepreneurship - United States Pharmaceutical technology - United States |
ISBN | 1-4214-1341-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Biology, industry, and the Cold War -- The insulin trophy -- Growing pains : commercial strains on a way of life -- The interferon derby : markets in credit, tournaments of value -- EPO : the making of the biotech blockbuster -- tPA the end of the beginning. |
Record Nr. | UNINA-9910792165703321 |
Rasmussen Nicolas <1962->
![]() |
||
Baltimore, Maryland : , : Johns Hopkins University Press, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Gene jockeys : life science and the rise of biotech enterprise / / Nicolas Rasmussen |
Autore | Rasmussen Nicolas <1962-> |
Pubbl/distr/stampa | Baltimore, Maryland : , : Johns Hopkins University Press, , 2014 |
Descrizione fisica | 1 online resource (260 p.) |
Disciplina | 660.6 |
Soggetto topico |
Biotechnology - United States
Entrepreneurship - United States Pharmaceutical technology - United States |
ISBN | 1-4214-1341-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Biology, industry, and the Cold War -- The insulin trophy -- Growing pains : commercial strains on a way of life -- The interferon derby : markets in credit, tournaments of value -- EPO : the making of the biotech blockbuster -- tPA the end of the beginning. |
Record Nr. | UNINA-9910816909003321 |
Rasmussen Nicolas <1962->
![]() |
||
Baltimore, Maryland : , : Johns Hopkins University Press, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Genome-based therapeutics : targeted drug discovery and development : workshop summary / / Adam C. Berger and Steve Olson, Rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
Descrizione fisica | 1 online resource (109 p.) |
Disciplina | 615.1 |
Soggetto topico |
Drugs - United States - Design
Pharmaceutical technology - United States Pharmaceutical industry - United States Genomics - United States |
Soggetto genere / forma | Electronic books. |
ISBN | 0-309-26025-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction -- The current landscape -- Case studies: The development of Crizotinib for treatment of non-small-cell lung cancer; Use of genetics to inform drug development for the treatment of schizophrenia; A genetic approach to the treatment of cystic fibrosis -- Emerging technologies in drug development: Large-scale whole-genome sequencing; The value of clinical next-generation sequencing to drug developers; The uses of genomic information -- Evolving paradigms: Foundations and drug development: an example; Genomics and regulatory science; Pharmacy benefit management and pharmacogenomics; Repurposing of drugs -- Forging collaborative strategies for the development of personalized medicine: The need for collaboration; FDA initiatives; NCATS initiatives; Biospecimens and databases; Reducing health disparities; Patient and physican education; An emphasis on the science. |
Record Nr. | UNINA-9910463952803321 |
Washington, District of Columbia : , : National Academies Press, , [2012] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Genome-based therapeutics : targeted drug discovery and development : workshop summary / / Adam C. Berger and Steve Olson, Rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
Descrizione fisica | 1 online resource (109 p.) |
Disciplina | 615.1 |
Soggetto topico |
Drugs - United States - Design
Pharmaceutical technology - United States Pharmaceutical industry - United States Genomics - United States |
ISBN |
0-309-26027-2
0-309-26025-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction -- The current landscape -- Case studies: The development of Crizotinib for treatment of non-small-cell lung cancer; Use of genetics to inform drug development for the treatment of schizophrenia; A genetic approach to the treatment of cystic fibrosis -- Emerging technologies in drug development: Large-scale whole-genome sequencing; The value of clinical next-generation sequencing to drug developers; The uses of genomic information -- Evolving paradigms: Foundations and drug development: an example; Genomics and regulatory science; Pharmacy benefit management and pharmacogenomics; Repurposing of drugs -- Forging collaborative strategies for the development of personalized medicine: The need for collaboration; FDA initiatives; NCATS initiatives; Biospecimens and databases; Reducing health disparities; Patient and physican education; An emphasis on the science. |
Record Nr. | UNINA-9910787308203321 |
Washington, District of Columbia : , : National Academies Press, , [2012] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Genome-based therapeutics : targeted drug discovery and development : workshop summary / / Adam C. Berger and Steve Olson, Rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
Descrizione fisica | 1 online resource (109 p.) |
Disciplina | 615.1 |
Soggetto topico |
Drugs - United States - Design
Pharmaceutical technology - United States Pharmaceutical industry - United States Genomics - United States |
ISBN |
0-309-26027-2
0-309-26025-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction -- The current landscape -- Case studies: The development of Crizotinib for treatment of non-small-cell lung cancer; Use of genetics to inform drug development for the treatment of schizophrenia; A genetic approach to the treatment of cystic fibrosis -- Emerging technologies in drug development: Large-scale whole-genome sequencing; The value of clinical next-generation sequencing to drug developers; The uses of genomic information -- Evolving paradigms: Foundations and drug development: an example; Genomics and regulatory science; Pharmacy benefit management and pharmacogenomics; Repurposing of drugs -- Forging collaborative strategies for the development of personalized medicine: The need for collaboration; FDA initiatives; NCATS initiatives; Biospecimens and databases; Reducing health disparities; Patient and physican education; An emphasis on the science. |
Record Nr. | UNINA-9910824065303321 |
Washington, District of Columbia : , : National Academies Press, , [2012] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 : report (to accompany H.R. 4369) |
Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2021] |
Descrizione fisica | 1 online resource (16 pages) |
Collana | Report / 117th Congress, 1st session, House of Representatives |
Soggetto topico |
Pharmaceutical technology - United States
Drug development - United States Medical innovations - Law and legislation - United States |
Soggetto genere / forma | Legislative materials. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 |
Record Nr. | UNINA-9910716998003321 |
[Washington, D.C.] : , : [U.S. Government Publishing Office], , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 : report (to accompany H.R. 4866) |
Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] |
Descrizione fisica | 1 online resource (16 pages) |
Disciplina | 1.1/8:116-513 |
Collana | Report / 116th Congress, 2d session, House of Representatives |
Soggetto topico |
Pharmaceutical technology - United States
Pharmaceutical industry - United States Pharmaceutical industry Pharmaceutical technology |
Soggetto genere / forma | Legislative materials. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 |
Record Nr. | UNINA-9910715152703321 |
[Washington, D.C.] : , : [U.S. Government Publishing Office], , [2020] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|